
Alcon to Acquire LumiThera, Maker of Photobiomodulation Device for Dry AMD
Alcon has announced plans to acquire LumiThera, strengthening its vitreoretinal surgery portfolio with the addition of LumiThera’s photobiomodulation (PBM) device for the treatment of early to intermediate dry age-related macular degeneration (AMD). …